Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia  Yufei Chen, Kenneth L. Jones, Konstantinos Anastassiadis,

Slides:



Advertisements
Similar presentations
Volume 19, Issue 1, Pages (January 2011)
Advertisements

Transcriptional activation by MLL fusion proteins in leukemogenesis
Volume 14, Issue 1, Pages (January 2014)
Volume 27, Issue 4, Pages (April 2015)
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation.
Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and.
Accelerating drug discovery: Open source cancer cell biology?
Ectopic expression of HOXC6 blocks myeloid differentiation and predisposes to malignant transformation  Melanie Wurm, John Kowalski, Dirk Heckl, Xiao-Bing.
by Christopher J. Ott, Nadja Kopp, Liat Bird, Ronald M
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Volume 25, Issue 4, Pages (April 2014)
Volume 33, Issue 1, Pages (July 2010)
Michael W.M. Kühn, Scott A. Armstrong  Cancer Cell 
Volume 11, Issue 2, Pages (August 2012)
Volume 8, Issue 4, Pages (April 2011)
Volume 2, Issue 4, Pages (April 2008)
Integrated analysis of miRNA and mRNA during differentiation of human CD34+ cells delineates the regulatory roles of microRNA in hematopoiesis  Nalini.
Volume 6, Issue 1, Pages (January 2014)
Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α
Volume 43, Issue 4, Pages (August 2011)
Valentina Manfé, Edyta Biskup, Peter Johansen, Maria R
Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function  Marta A. Walasek, Leonid V.
Spatiotemporal Brassinosteroid Signaling and Antagonism with Auxin Pattern Stem Cell Dynamics in Arabidopsis Roots  Juthamas Chaiwanon, Zhi-Yong Wang 
Meghan Bliss-Moreau, Cristian Coarfa, Preethi H
Volume 17, Issue 2, Pages (February 2010)
Volume 31, Issue 6, Pages e6 (June 2017)
Megakaryocyte-derived excessive transforming growth factor β1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia  Yuemin.
Volume 23, Issue 3, Pages (March 2013)
Epigenetic Roles of MLL Oncoproteins Are Dependent on NF-κB
Christine V. Ichim, Džana D
Qiuping He, Suwei Gao, Junhua Lv, Wei Li, Feng Liu 
Volume 42, Issue 6, Pages (June 2015)
Volume 2, Issue 4, Pages (April 2008)
Sphingosine-1-phosphate signaling modulates terminal erythroid differentiation through the regulation of mitophagy  Chong Yang, Michihiro Hashimoto, Quy.
Juana Serrano-Lopez, Kalpana Nattamai, Nicholas A. Pease, Miranda S
Volume 33, Issue 6, Pages (December 2010)
Experimental Hematology
Volume 22, Issue 2, Pages (January 2018)
RUNX1 and the endothelial origin of blood
Volume 6, Issue 1, Pages (January 2014)
Volume 10, Issue 3, Pages (March 2018)
Volume 54, Issue 5, Pages (June 2014)
Volume 6, Issue 3, Pages (February 2014)
A Genetic Screen Identifies TCF3/E2A and TRIAP1 as Pathway-Specific Regulators of the Cellular Response to p53 Activation  Zdenek Andrysik, Jihye Kim,
Volume 17, Issue 10, Pages (December 2016)
Volume 53, Issue 2, Pages (January 2014)
Application of small molecule CHIR99021 leads to the loss of hemangioblast progenitor and increased hematopoiesis of human pluripotent stem cells  Yekaterina.
Volume 49, Issue 1, Pages 1-3 (January 2013)
Volume 16, Issue 12, Pages (September 2016)
Masayuki Yamashita, Eriko Nitta, Toshio Suda  Cell Stem Cell 
Volume 8, Issue 4, Pages (April 2011)
Volume 14, Issue 8, Pages (August 2007)
Inside This Issue Experimental Hematology
Volume 25, Issue 4, Pages (April 2014)
Interleukin-18 plays a dispensable role in murine and likely also human bone marrow failure  Zhijie Wu, Valentina Giudice, Jichun Chen, Wanling Sun, Zenghua.
Volume 25, Issue 1, Pages (January 2017)
Volume 16, Issue 1, Pages (January 2015)
Deciphering the Innate Lymphoid Cell Transcriptional Program
AZA treatment induces a distinct gene-expression pattern in stromal cells. AZA treatment induces a distinct gene-expression pattern in stromal cells. (A-C)
Volume 39, Issue 3, Pages (August 2010)
Volume 23, Issue 3, Pages (September 2005)
Volume 17, Issue 4, Pages (October 2015)
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer, Zhike Zi 
An Mll-Dependent Hox Program Drives Hematopoietic Progenitor Expansion
Volume 17, Issue 5, Pages (May 2010)
Volume 19, Issue 1, Pages (January 2011)
Volume 26, Issue 10, Pages (October 2018)
Volume 10, Issue 7, Pages (February 2015)
Volume 12, Issue 2, Pages (February 2013)
Presentation transcript:

Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia  Yufei Chen, Kenneth L. Jones, Konstantinos Anastassiadis, Andrea Kranz, A. Francis Stewart, Jolanta Grembecka, Matthew Meyerson, Patricia Ernst  Experimental Hematology  Volume 69, Pages 37-42 (January 2019) DOI: 10.1016/j.exphem.2018.10.001 Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 1 Loss of Men1 versus Mll1;Mll2 shows different cellular and molecular effects in MLL-AF9-transformed cells. (A,B) Representative FACS plots (A) and quantification (B) showing BrdU incorporation and DNA content in Men1- and Mll1;Mll2-deficient MLL-AF9 cells. MLL-AF9-transformed cells were treated with ethanol or 4-OHT for 24 hours to induce the deletion of Men1 or Mll1;Mll2. After an additional 4 days, cells were incubated with BrdU for 30 minutes and were processed to detect BrdU and DNA content by flow cytometry. The apoptotic sub-G0/G1, G2M, S, and G0/G1 gates are shown. (C) Relative Annexin V+ cell percentage compared with control cells 3 days after initiating gene deletion. (D) Venn diagram showing the overlap of downregulated and upregulated genes with Men1 and Mll1;Mll2 deletion. Differentially expressed genes (Supplementary Table E1, online only, available at www.exphem.org) were identified as described in the Methods. (E) qRT-PCR of select genes after Men1 or Mll1;Mll2 deletion in MLL-AF9-transformed cells. Gene expression was determined 3 days after initiating gene deletion. Data are represented as averages ± standard deviation (SD). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. One representative experiment of five is shown. (F) GSEA plots showing enrichment of MLL-AF9 direct binding targets or Dot1L-dependent genes [16] and MLL-AF9-regulated genes [15] in Men1-deficient (4-OHT) MLL-AF9-transformed cells. Experimental Hematology 2019 69, 37-42DOI: (10.1016/j.exphem.2018.10.001) Copyright © 2018 Elsevier Ltd Terms and Conditions

Figure 2 Menin inhibitors phenocopy Men1 deletion and collaborate with Mll1;Mll2 loss to kill leukemia cells. (A) GSEA plots showing enrichment of MI-2-2-regulated genes [20] in Men1-deleted MLL-AF9 cells and in Mll1;Mll2-deleted MLL-AF9 cells. (B) qRT-PCR of selected target genes after MI-2-2 treatment in MLL-AF9-transformed cells. Gene expression was determined 72 hours after treatment. Data are represented as averages ± standard deviation (SD). (C,D) Relative cell viability after and MI-2-2 (C) and MI-2 (D) treatment in MLL-AF9-transformed cells with or without Mll1;Mll2. MLL-AF9-transformed cells with the genotype of Cre+;Mll1F/F;Mll2F/F were treated with ethanol or 4-OHT for 24 hours, washed, and then treated with compound or vehicle for 3 additional days. Cell viabilities were all normalized to the corresponding vehicle (ethanol) control. Data are represented as mean ± SD. One representative experiment of two is shown. Experimental Hematology 2019 69, 37-42DOI: (10.1016/j.exphem.2018.10.001) Copyright © 2018 Elsevier Ltd Terms and Conditions